Skip to content
AnecdotalCathelicidin peptide for innate immunity

LL-37

Cathelicidin-derived antimicrobial & immune-modulating peptide.

Overview

Binds to formyl peptide receptors and disrupts pathogen cell membranes.

Proposed mechanism

Cathelicidin-derived antimicrobial peptide disrupting microbial membranes, modulating chemokines, and promoting angiogenesis via FPRL1.

What the evidence supports

Evidence rests primarily on self-reported experience. Controlled studies are lacking.

Graded Anecdotal

Case reports, clinician notes, and user-reported outcomes. Recorded for completeness and labelled plainly so it is never mistaken for data.

Key citations

Representative primary sources, including results that did not favour the compound.

  1. [1]

    LL-37 antimicrobial activity

    · DOI:10.1038/nri2435 · 2008

  2. [2]

    LL-37 antimicrobial activity (2008)

    · · 0

Citation records in this build are illustrative placeholders for the design.

Reference information for research purposes. Not medical advice, and not a recommendation to use any compound. Many entries describe substances that are not approved for human use.

Related profiles